rs137852522
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM1PM2PP3_ModeratePP5_Very_Strong
The NM_001278116.2(L1CAM):c.3581C>T(p.Ser1194Leu) variant causes a missense change. The variant allele was found at a frequency of 0.000000911 in 1,097,854 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: not found (cov: 24)
Exomes 𝑓: 9.1e-7 ( 0 hom. 0 hem. )
Consequence
L1CAM
NM_001278116.2 missense
NM_001278116.2 missense
Scores
7
8
2
Clinical Significance
Conservation
PhyloP100: 4.73
Genes affected
L1CAM (HGNC:6470): (L1 cell adhesion molecule) The protein encoded by this gene is an axonal glycoprotein belonging to the immunoglobulin supergene family. The ectodomain, consisting of several immunoglobulin-like domains and fibronectin-like repeats (type III), is linked via a single transmembrane sequence to a conserved cytoplasmic domain. This cell adhesion molecule plays an important role in nervous system development, including neuronal migration and differentiation. Mutations in the gene cause X-linked neurological syndromes known as CRASH (corpus callosum hypoplasia, retardation, aphasia, spastic paraplegia and hydrocephalus). Alternative splicing of this gene results in multiple transcript variants, some of which include an alternate exon that is considered to be specific to neurons. [provided by RefSeq, May 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 14 ACMG points.
PM1
In a modified_residue Phosphoserine (size 0) in uniprot entity L1CAM_HUMAN
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.916
PP5
Variant X-153862856-G-A is Pathogenic according to our data. Variant chrX-153862856-G-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 9993.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
L1CAM | NM_001278116.2 | c.3581C>T | p.Ser1194Leu | missense_variant | 29/29 | ENST00000370060.7 | NP_001265045.1 | |
L1CAM | NM_000425.5 | c.3581C>T | p.Ser1194Leu | missense_variant | 28/28 | NP_000416.1 | ||
L1CAM | NM_024003.3 | c.3569C>T | p.Ser1190Leu | missense_variant | 27/27 | NP_076493.1 | ||
L1CAM | NM_001143963.2 | c.3554C>T | p.Ser1185Leu | missense_variant | 26/26 | NP_001137435.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
L1CAM | ENST00000370060.7 | c.3581C>T | p.Ser1194Leu | missense_variant | 29/29 | 5 | NM_001278116.2 | ENSP00000359077 | A1 |
Frequencies
GnomAD3 genomes Cov.: 24
GnomAD3 genomes
Cov.:
24
GnomAD4 exome AF: 9.11e-7 AC: 1AN: 1097854Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 363230
GnomAD4 exome
AF:
AC:
1
AN:
1097854
Hom.:
Cov.:
30
AF XY:
AC XY:
0
AN XY:
363230
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 24
GnomAD4 genome
Cov.:
24
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
X-linked hydrocephalus syndrome Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Genetics Institute, Tel Aviv Sourasky Medical Center | May 12, 2021 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Dec 01, 1994 | - - |
MASA syndrome Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Dec 01, 1994 | - - |
Inborn genetic diseases Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 07, 2015 | The p.S1194L variant (also known as c.3581C>T) is located in exon 28 of the L1CAM gene. This alteration results from a C to T substitution at nucleotide position 3581. The serine at codon 1194 is replaced by leucine, an amino acid with dissimilar properties. In one published study, this variant was observed to segregate with disease in two maternally related male probands diagnosed with MASA syndrome and two obligate carrier females and was absent in two unaffected maternally related males. An additional affected male in this family was diagnosed with congenital hydrocephalus, extreme macrocephaly, severe spasticity, and MR (HSAS) but died at age 15 years and was untested in this family study (Fransen, E et al. Hum Mol Genet 1994;3:2255-2256). This variant has been observed in a male proband tested by our laboratory diagnosed with macrocephaly, agenesis of the corpus collosum, and periventricular volume loss on MRI and whose family history consististed of two maternally related males in separate generations diagnosed with hydrocephalus and mental retardation respectively. This variant was not reported in population-based cohorts in the following databases: Database of Single Nucleotide Polymorphisms (dbSNP), NHLBI Exome Sequencing Project (ESP) and 1000 Genomes Project. Based on protein sequence alignment, this amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic; however, its clinical significance remains unclear. - |
Hydrops fetalis;C3278123:Severe hydrocephalus Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Center for Reproductive Medicine, Peking University Third Hospital | Oct 16, 2019 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Mar 31, 2022 | Published functional studies demonstrate a damaging effect due to reduction of neuronal migration and MAP kinase activation (Thelen et al., 2002); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 11438988, 10908608, 11222639, 28152038, 7881431, 30197081, 31680349, 12077189) - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Pathogenic
.;D;.;D;.
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;.;D;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D;D;D
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
.;M;.;.;.
MutationTaster
Benign
A;A;A;A;A;A;A
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D;D;D;D
REVEL
Pathogenic
Sift
Uncertain
D;D;D;D;D
Sift4G
Uncertain
D;D;D;D;D
Polyphen
1.0, 1.0
.;D;.;.;D
Vest4
MutPred
0.75
.;Gain of catalytic residue at S1194 (P = 0.009);.;.;.;
MVP
MPC
1.4
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at